EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Software-Assisted LC-HRMS Annotation of Urinary Modified Nucleosides: Proof-of-Concept in Prostate Cancer

Enrico Taglioni, Andrea Cerrato, Aldo Laganà, Carmela Maria Montone, Anna Laura Capriotti

ACS Measurement Science Au · 03.11.2026

DOI: 10.1021/acsmeasuresciau.6c00189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Measurement Science Au, online erschienen am 03.11.2026. Verfasst von Enrico Taglioni und 4 weiteren Autor:innen. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sapienza Università di Roma, Fondazione Umberto Veronesi.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-resolution mass spectrometry (HRMS) has greatly expanded the untargeted annotation of RNA modifications and the investigation of epitranscriptomic profiles at the single-nucleoside level. However, the comprehensive characterization of endogenous modified nucleosides in biological matrices remains challenging due to their low abundance, structural diversity, and isomerism, despite their emerging role as biomarkers of RNA turnover, cellular stress, and disease-related metabolic alterations. We developed an integrated LC-HRMS suspect screening workflow for the structured annotation of modified nucleosides in clinically relevant samples. The approach combines a curated in-house mass list of biologically relevant nucleoside modifications with a dedicated data-processing pipeline, enabling efficient feature prioritization and the annotation of 60 nucleoside-related compounds with different levels of identification confidence. Where authentic analytical standards were available, selected annotations were further confirmed by agreement in accurate mass, retention time, and MS/MS fragmentation. Chromatographic conditions were optimized to resolve isomeric species, while stepped normalized collision energy acquisition provided complementary fragmentation data to support structural annotation. The workflow was further applied to a small pilot set of urine samples from patients with prostate cancer (PCa) and benign prostatic hyperplasia (BPH) to illustrate its applicability in a clinically relevant matrix. Exploratory statistical analysis was used only to visualize preliminary abundance trends between the two groups. The results highlight the ability of the workflow to prioritize modified-nucleoside features for further investigation while requiring minimal sample preparation. Although confirmation of the remaining low-abundance and isomeric annotations and assessment of their biological relevance will require further validation, and larger independent cohorts, the proposed workflow provides a practical framework for systematic modified-nucleoside annotation and hypothesis generation in future metabolomics studies.

Förderung

  • Sapienza Università di Roma
  • Fondazione Umberto Veronesi

Zitieren

APA

Taglioni, E., Cerrato, A., Laganà, A., Montone, C. M., & Capriotti, A. L. (2026). Software-Assisted LC-HRMS Annotation of Urinary Modified Nucleosides: Proof-of-Concept in Prostate Cancer. ACS Measurement Science Au. https://doi.org/10.1021/acsmeasuresciau.6c00189

Vancouver

Taglioni E, Cerrato A, Laganà A, Montone CM, Capriotti AL. Software-Assisted LC-HRMS Annotation of Urinary Modified Nucleosides: Proof-of-Concept in Prostate Cancer. ACS Measurement Science Au. 2026. doi:10.1021/acsmeasuresciau.6c00189

BibTeX
@article{Taglioni2026,
  author = {Taglioni, Enrico and Cerrato, Andrea and Laganà, Aldo and Montone, Carmela Maria and Capriotti, Anna Laura},
  title = {Software-Assisted LC-HRMS Annotation of Urinary Modified Nucleosides: Proof-of-Concept in Prostate Cancer},
  journal = {ACS Measurement Science Au},
  year = {2026},
  doi = {10.1021/acsmeasuresciau.6c00189}
}
Kostenlos starten →